Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...

A 60-year-old man in Spain went to the doctor complaining of a headache that he couldn’t shake. It had started two weeks prior and was only getting worse. He also said he had noticed subtle changes in ...

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%. The study, led ...

The startup Coherence Neuro is now testing a brain-computer interface that could one day use electrical stimulation to prevent tumors from growing. Coherence Neuro says it temporarily placed its ...

Novocure’s tumor-treating electric fields device missed its primary endpoint in a late-stage glioblastoma trial. The Swiss medtech’s product has an FDA approval as Optune Gio. The device is licensed ...

The following is a summary of a story by Adriana Difranco on MADE FOR THIS. Chemotherapy drugs for brain tumors typically haven’t been able to get past the blood-brain barrier, says Duke neurosurgeon ...

As the state investigates a possible cancer cluster at a high school, many Herald readers have asked whatever happened with the potential tumor cluster at a local hospital. Seven current and former ...

A new report on the investigation into a potential hospital cancer cluster is shedding light on the 11 nurses who were diagnosed with brain tumors. Eleven current and former nurses in Newton-Wellesley ...

Stephen De La Torre's brain tumor was the size of a battery and close to his brain stem, so doctors found a way to shrink the cancer — and avoid exposing healthy tissues to radiation Kurt ...

Brain tumors are one of the most devastating consequences of cancer’s spread—hard to treat and highly deadly. Scientists have found that using a radioactive implant precisely where a tumor was removed ...

High-precision liver and tumor segmentation is a cornerstone of digital oncology, yet its clinical deployment remains constrained by two persistent challenges: the scarcity of pixel-level annotations ...